ApprovalTrail

Ingredient

Naphazoline Hydrochloride

Products in Health Canada’s databases that list Naphazoline Hydrochloride as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
39
9 authorized now
Natural health products
0
0 active licences
Notices of Compliance
0
Products in all
39

Drug products

Authorized products first.

NameDINStatus
CLEAR EYES (0.012 %)Prestige Brands Inc · Status since Mar 200402248060Marketed
CLEAR EYES ALLERGY (0.012 %)Prestige Brands Inc · Status since Mar 200402248059Marketed
CLEAR EYES EXTRA STRENGTH REDNESS RELIEF (0.03 %)Prestige Brands Inc · Status since Apr 201102360837Marketed
NAPHCON A (0.025 %)Alcon Canada Inc. · Status since Oct 201900481408Marketed
SOOTHE ALLERGY (0.02675 %)Bausch & Lomb Inc. · Status since May 201600750794Marketed
VISINE FOR ALLERGY WITH ANTIHISTAMINE (0.025 %)Kenvue Canada Inc. · Status since Oct 202602242764Marketed
DIOPTICON A LIQ (0.025 %)Pharma Stulln Inc. · Status since Jan 202002026465Dormant
DIOPTICON LIQ 0.1% (0.1 %)Pharma Stulln Inc. · Status since Aug 201902026546Dormant
ODAN-NAPHAZOLINE (0.1 %)Odan Laboratoriesltd · Status since Jun 201700626570Dormant
ALBALON (0.1 %)AbbVie Corporation · Status since May 202600001147Cancelled Post Market
ALBALON A (.05 %)Allergan Inc · Status since Jul 201700433519Cancelled Post Market
ALLERGY EYE DROPS (0.02675 %)Bausch & Lomb Inc. · Status since Aug 201702394561Cancelled Post Market
BLUE COLLYRIUM (0.5 MG)Sandoz Canada Inc. · Status since Aug 201902171937Cancelled Post Market
CLEAR EYES ACR BY MURINE (0.1 MG)Abbott Laboratories Co. · Status since Oct 200302232454Cancelled Post Market
CLEAR EYES BY MURINE EYE DPS (.012 %)Abbott Laboratories Co. · Status since Oct 200300367036Cancelled Post Market
CLEAR EYES FOR DRY EYES PLUS REDNESS RELIEF (0.012 %)Prestige Brands Inc · Status since Mar 201402294958Cancelled Post Market
COLLYRE BLEU (0.5 MG)Sabex Inc. · Status since Nov 199700787043Cancelled Post Market
COOPER A.R. (.5 MG)Coopervision Ltd. · Status since Mar 199802174243Cancelled Post Market
NAPHCON FORTE (0.1 %)Alcon Canada Inc. · Status since Nov 201700390283Cancelled Post Market
ONRECTAL (.4 MG)Herbes Universelles inc. · Status since Jul 200900485748Cancelled Post Market
OPCON OPH SOLN 0.1% (.1 %)Bausch & Lomb Canada Inc. · Status since Sep 199600750786Cancelled Post Market
OPTI-TEARS ALLERGY (0.025 %)Alcon Canada Inc. · Status since Feb 202402445573Cancelled Post Market
OPTI-TEARS RED EYE (0.1 %)Alcon Canada Inc. · Status since Feb 202402449609Cancelled Post Market
OPTREX PLUS DECONGESTANT EYE DROPS (0.01 %)Optrex Labs Ltd. · Status since Sep 199600751316Cancelled Post Market
OPTREX PLUS DECONGESTANT EYE DROPS (0.01 %)Knoll Pharma Inc. · Status since Jul 199702185504Cancelled Post Market
R.O.-NAPHZ (.1 %)Richmond Pharmaceuticals Inc. · Status since Aug 199701901664Cancelled Post Market
REACTINE EYE DROPS (0.025 %)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Jan 202602237000Cancelled Pre Market
RED AWAY (.1 %)Rivex Ophthalmics Inc. · Status since Jul 200302212986Cancelled Post Market
REDNESS EYE DROPS (0.012 %)Bausch & Lomb Inc. · Status since Aug 201702393506Cancelled Post Market
REFRESH EYE ALLERGY RELIEF (0.051 %)AbbVie Corporation · Status since Nov 202502315890Cancelled Post Market
REFRESH REDNESS RELIEF (0.1 %)Allergan Inc · Status since Nov 202202315920Cancelled Post Market
RHINO MEX (.1 %)Laboratoires Charton Laboratories · Status since Sep 199900341649Cancelled Post Market
SOOTHE REDNESS (0.012 %)Bausch & Lomb Inc. · Status since Dec 202400764647Cancelled Post Market
STERITEARS AR (0.05 %)Laboratoires Sterigen Inc · Status since Jul 202102329875Cancelled Pre Market
VASOCON A EYE DROPS (.5 MG)Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc · Status since Mar 200502133369Cancelled Post Market
VASOCON A OPH SOLN (.5 MG)Iolab Pharmaceuticals · Status since Sep 199600759899Cancelled Post Market
VASOCON EYE DROPS (1 MG)Novartis Ophthalmics Novartis Pharmaceuticals (Canada) Inc · Status since Aug 200602133350Cancelled Post Market
VASOCON OPH SOLN 0.1% (.1 %)Iolab Pharmaceuticals · Status since Sep 199600759880Cancelled Post Market
ZINCFRIN A (0.05 %)Alcon Canada Inc. · Status since Apr 200900042641Cancelled Post Market